AlphAIalphai — Financial news for AI agents
dailypolitical.comJUN 43 min read$A

Agilent Technologies (A) – Analysts’ Weekly Ratings Updates

Agilent Technologies (NYSE: A) saw multiple analyst rating and target changes. HSBC cut its target to $165 (buy), TD Cowen raised to $155 (buy), Barclays to $145 (overweight), Wells Fargo to $160 (overweight), and Bank of America set $145 (buy). Royal Bank of Canada started coverage with an outperform $153 target. Agilent also announced a $0.255 quarterly dividend, payable July 22 to holders of record June 30.

Original reporting
dailypolitical.com
Published Jun 4, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Agilent Technologies (A) – Analysts’ Weekly Ratings Updates — source image
Source · dailypolitical.com
Decision brief

The 30-second read

$ANeutralMed
01

Why it matters

The main tradable element is sentiment/positioning around analyst consensus, plus a known dividend/ex-date that can affect short-term demand.

02

Market read

Multiple upgrades and target adjustments suggest consensus is being recalibrated, but without new operational data the effect is likely sentiment-driven.

03

What to watch

Dividend timing (ex-dividend June 30) may attract yield-focused flows that partially offset negative target revisions.

Relevance 6/10Novelty 4/10Timing: After-hours/overnight positioning around the latest analyst updates (published 2026-06-04).

Background

The piece compiles recent brokerage rating and price-target updates for Agilent Technologies and notes a quarterly dividend schedule.

Company-level read

Ticker impact

$ANeutralMedium confidence
Context

Agilent (A) saw multiple broker rating changes and price-target revisions, including HSBC lowering to $165 and BofA upgrading to Buy with a $145 target.

Expected impact

Choppy/mean-reverting price action is likely as target changes compete, with upside bias if upgrades dominate.

Evidence & confidence

The article is a recap of analyst actions (not fundamentals) but the breadth of revisions can still affect positioning and short-term sentiment.

Market effects

Sector

Analyst sentiment shifts for life-science tools can influence the broader lab-instrument/diagnostics complex via read-across.

Regional

Primarily US-listed sentiment; could spill into European broker desks’ positioning for global peers.

Global

Limited—this is company-specific analyst coverage rather than a global demand or regulatory shock.

Counterpoint

What could challenge this read

Because these are mostly rating/target changes (not new earnings or guidance), the market may already discount them and price impact could fade quickly.

Key entities

  • company
    Agilent Technologies

    Subject of the analyst rating/price-target updates and the dividend announcement.

Read at source← All news

Related articles

JUL 23
$AMed

Agilent Technologies Inc.: Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Technologies (NYSE: A) said the EU approved its PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic for epithelial ovarian, fallopian tube, or primary peritoneal carcinoma to identify patients whose tumors express PD-L1 and may be eligible for Merck’s KEYTRUDA (pembrolizumab). Agilent said it is the eighth CE-marked indication for this test.

finanznachrichten.de3 min
MAY 29
$ARMMedAI 9/10

Stocks Rebound Amid News of a US-Iran Deal

US Q1 GDP was revised to +1.6% (q/q annualized) from +2.0% expected; Q1 personal consumption was cut to +1.4%, while core PCE rose to a 3-year high of +4.4%. Apr new home sales fell 6.2% m/m to 622k. Stocks rebounded after Axios reported a preliminary US-Iran deal to extend the ceasefire 60 days and begin nuclear talks. Fed hawkishness weighed; markets priced a 3% chance of a 25 bp June cut.

finance.yahoo.com7 min
MAY 29
$INFQMedAI 9/10

11 Stocks Racking Up Monstrous Gains

On Thursday, 11 stocks with market caps above $2B and at least 5M shares traded posted double-digit gains, helping all three US indices finish higher (Nasdaq +0.91%, S&P 500 +0.58%, Dow +0.05%). Infleqtion rose 14.94% on plans to triple UK capacity; Best Buy gained 15.80% after Q1 fiscal 2027 results and guidance; Clover Health jumped 16.43% after a court order tied to 2026 star ratings; Agilent rose on Q2 earnings and raised outlook; Dollar Tree climbed 17.87% on Q1 revenue and sales growth.

insidermonkey.com6 min
MAY 28
$AMedAI 9/10

Benzinga

BofA Securities said Agilent Technologies’ fiscal Q2 results beat expectations, citing high single-digit growth in the Instruments segment driven by share gains, new platforms and replacement activity, and noting management raised full-year guidance by the size of the beat. RBC reported revenue of $1.83B (~6.3% organic growth) above estimates and also cited guidance increases. Shares rose 16.9% to $135.38.

benzinga.com2 min
MAY 28
$IBMMedAI 9/10

Stocks making the biggest moves midday: Unusual Machines, Snowflake, Arm, Dollar Tree & more

Midday movers: IBM rose ~3% after filing it will invest over $10B in quantum computing over five years. Arm jumped >15% as Mizuho raised its target to $360. Norfolk Southern and Union Pacific fell ~4% after the Surface Transportation Board halted review of their $71.5B merger. Snowflake surged 37% on Q2 margin/product revenue guidance; Dollar Tree rose 18% after raising FY earnings outlook.

cnbc.com8 min
MAY 28
$SNOWMedAI 9/10

S&P 500 Hits Record Highs, Snowflake Jumps 37% On AI Boom - Agilent Technologies (NYSE:A), Advanced Micro

U.S. stocks rose to record highs after reports of a 60-day ceasefire extension between Washington and Tehran and phased resumption of Strait of Hormuz tanker traffic. The S&P 500 gained 0.5% to 7,557.85. April PCE was mixed (headline 3.8% YoY; core 3.3%). Snowflake jumped 37% on AI-cloud demand; Agilent rose 17% on fiscal Q2 revenue $1.83B and non-GAAP EPS $1.49, with raised guidance.

benzinga.com5 min